The Readout Loud 274: Covid’s latest surge, Alnylam at the FDA, & the end of an era
Sep 14, 2023
Helen Branswell discusses the state of the pandemic and rollout of booster shots for Covid-19. They also talk about an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Introduction
00:00 • 2min
FDA Advisory Panel Votes in Favor of Alnylam Drug for ATTR CM
02:10 • 6min
The Use of the Six Minute Walk Test in Drug Development
08:08 • 4min
Bluebird Bio Restructuring Announcement
11:43 • 9min
The Surge of Weight Loss Treatments and a New Tracker
20:53 • 2min
FDA Approves COVID Booster Shots
23:13 • 16min